Get the latest tech news
New eczema treatment provides relief in Phase 2 human trials | Rezpeg is designed to rebalance the immune system by boosting regulatory T cells (Tregs), special cells that help calm inflammation.
A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the common side effects associated with other therapies.
A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the common side effects associated with other therapies. However, help may soon be at hand in the form of rezpegaldesleukin, an immunotherapy treatment developed by Nektar Therapeutics, which calms the symptoms of eczema from the inside out and has produced promising results in a recent clinical trial. Other mild-to-moderate side effects in Rezpeg patients included eosinophilia (a high number of eosinophils, a type of white blood cell that helps regulate inflammation) (7.8% vs. 2.7% placebo), fever (6.3%), headache (6.3%) and joint pain (5.0%).
Or read this on r/tech
